Porton Fine Chemicals Ltd Cash Flow Conversion Efficiency
Porton Fine Chemicals Ltd cash flow conversion efficiency. Based on the latest financial reports, Porton Fine Chemicals Ltd (300363) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥126.55 Million ≈ $18.52 Million USD) by net assets (CN¥5.49 Billion ≈ $803.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Porton Fine Chemicals Ltd (2009–2024)
Cash flow conversion efficiency of Porton Fine Chemicals Ltd from 2009 to 2024. This chart illustrates how Porton Fine Chemicals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300363 stock price for real-time trading data and today's change.
Porton Fine Chemicals Ltd Cash Flow Conversion Ratio Explained
Porton Fine Chemicals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Porton Fine Chemicals Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Porton Fine Chemicals Ltd ranked by their cash flow conversion efficiency. Also see market value of Porton Fine Chemicals Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thai President Foods Public Company Limited
BK:TFMAMA
|
0.024x |
|
Nanjing Sunlord Electronics Corporation LTD
SHE:300975
|
-0.001x |
|
Winpak Ltd.
TO:WPK
|
0.005x |
|
Gubre Fabrikalari TAS
IS:GUBRF
|
0.108x |
|
Diebold Nixdorf, Incorporated
NYSE:DBD
|
-0.021x |
|
Woolworths Holdings Ltd
JSE:WHL
|
0.247x |
|
SIRIUS REAL ESTATE LTD.
F:EYI
|
N/A |
|
Shanghai Chinafortune Co Ltd
SHG:600621
|
0.369x |
Annual Cash Flow Conversion Efficiency for Porton Fine Chemicals Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of Porton Fine Chemicals Ltd from 2009 to 2024. Review cash generation quality of Porton Fine Chemicals Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.41 Billion ≈ $791.83 Million |
CN¥405.53 Million ≈ $59.34 Million |
0.075x | -27.33% |
| 2023-12-31 | CN¥6.10 Billion ≈ $892.61 Million |
CN¥629.06 Million ≈ $92.05 Million |
0.103x | -73.97% |
| 2022-12-31 | CN¥6.47 Billion ≈ $947.10 Million |
CN¥2.56 Billion ≈ $375.26 Million |
0.396x | +245.42% |
| 2021-12-31 | CN¥4.19 Billion ≈ $612.56 Million |
CN¥480.17 Million ≈ $70.26 Million |
0.115x | -22.83% |
| 2020-12-31 | CN¥3.39 Billion ≈ $496.54 Million |
CN¥504.37 Million ≈ $73.81 Million |
0.149x | +29.63% |
| 2019-12-31 | CN¥3.06 Billion ≈ $448.41 Million |
CN¥351.37 Million ≈ $51.42 Million |
0.115x | +70.75% |
| 2018-12-31 | CN¥2.88 Billion ≈ $421.91 Million |
CN¥193.62 Million ≈ $28.33 Million |
0.067x | -66.38% |
| 2017-12-31 | CN¥1.45 Billion ≈ $212.07 Million |
CN¥289.46 Million ≈ $42.36 Million |
0.200x | -4.09% |
| 2016-12-31 | CN¥1.37 Billion ≈ $200.49 Million |
CN¥285.33 Million ≈ $41.75 Million |
0.208x | +118.72% |
| 2015-12-31 | CN¥1.18 Billion ≈ $172.60 Million |
CN¥112.31 Million ≈ $16.43 Million |
0.095x | -31.71% |
| 2014-12-31 | CN¥874.42 Million ≈ $127.96 Million |
CN¥121.92 Million ≈ $17.84 Million |
0.139x | -47.62% |
| 2013-12-31 | CN¥428.43 Million ≈ $62.69 Million |
CN¥114.05 Million ≈ $16.69 Million |
0.266x | -23.60% |
| 2012-12-31 | CN¥327.76 Million ≈ $47.96 Million |
CN¥114.21 Million ≈ $16.71 Million |
0.348x | +31.02% |
| 2011-12-31 | CN¥246.01 Million ≈ $36.00 Million |
CN¥65.43 Million ≈ $9.57 Million |
0.266x | +21.40% |
| 2010-12-31 | CN¥163.21 Million ≈ $23.88 Million |
CN¥35.75 Million ≈ $5.23 Million |
0.219x | -44.12% |
| 2009-12-31 | CN¥81.60 Million ≈ $11.94 Million |
CN¥31.99 Million ≈ $4.68 Million |
0.392x | -- |
About Porton Fine Chemicals Ltd
Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, produc… Read more